ArticleEuropean journal of medical research2025
Evaluation of microecological therapy in endometriosis through modulation of the gut microbiota.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Microbiota-Endometriosis Axis: An Immune-Endocrine Integration Model and Emerging Therapeutic Targets.International journal of molecular sciences · 2026Review
- Orchestrating the gut microbiota-mitochondrial-immune axis in gynecological diseases: mechanisms and dual-targeting therapeutic strategies.Frontiers in reproductive health · 2026Review
- Immune regulatory networks and gut microbiota-associated targets in endometriosis: an integrative multi-omics and network analysis.Open life sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndometriosis is a chronic inflammatory disease significantly affecting women's health and quality of life. The recent evidence highlights the role of gut microbiota dysbiosis in endometriosis pathogenesis, suggesting that gut microbiota modulation could be a promising therapeutic strategy.
objectivesThis study aimed to retrospectively evaluate the therapeutic efficacy of microecological therapy, via the modulation of gut microbiota, inflammatory and immune parameters, as an adjunct treatment for patients with endometriosis undergoing laparoscopic surgery.
methodsA retrospective analysis was conducted on 187 patients diagnosed with endometriosis from January 2022 to December 2023. Patients were grouped into a surgery-only group and a surgery-plus-microecological therapy group. Clinical outcomes including gastrointestinal recovery, postoperative complications, and pain were recorded. Gut microbiota composition, systemic inflammation markers, estradiol levels, intestinal barrier function (lipopolysaccharide, LPS), and intestinal mucosal immunity were also analyzed.
resultsPatients receiving microecological therapy showed significantly improved gastrointestinal recovery, decreased postoperative pain, reduced complication rates, and enhanced quality of life compared with surgery-only controls. Microecological therapy notably reduced systemic inflammation, as evidenced by lower serum IL-6, TNF-α, and LPS levels, and decreased estradiol concentrations, and significantly increased beneficial gut microbiota abundance and improved mucosal immunity markers.
conclusionMicroecological therapy effectively enhances postoperative outcomes, reduces systemic inflammation, restores gut microbiota balance, and strengthens intestinal mucosal immunity in endometriosis patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.